WallStSmart
ACRV

Acrivon Therapeutics, Inc. Common Stock

NASDAQ: ACRV · HEALTHCARE · BIOTECHNOLOGY

$1.81
-4.74% today

Updated 2026-04-29

Market cap
$70.13M
P/E ratio
P/S ratio
EPS (TTM)
$-2.02
Dividend yield
52W range
$1 – $4
Volume
0.9M

Acrivon Therapeutics, Inc. Common Stock (ACRV) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+37.8%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+18.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-1.8%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$-0.49-7.4%$1.64$1.66+1.2%
2025-11-13$-0.47+59.5%$2.28$2.24-1.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.46$-0.49-7.4%
2025-09-30$-1.16$-0.47+59.5%
2025-06-30$-1.09$-0.55+49.5%
2025-03-31$-1.01$-0.51+49.5%
2024-12-31$-0.77$-0.60+22.1%$848000.00-55.0%
2024-09-30$-0.74$-0.59+20.3%
2024-06-30$-0.75$-0.52+30.7%
2024-03-31$-0.84$-0.73+13.1%
2023-12-31$-0.73$-0.86-17.8%$1.88M
2023-09-30$-0.71$-0.66+7.0%
2023-06-30$-0.65$-0.63+3.1%
2023-03-31$-0.60$-0.58+3.3%

Frequently asked questions

Has Acrivon Therapeutics, Inc. Common Stock beaten earnings estimates?
Acrivon Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +37.8% over the last 4 quarters.
How does ACRV stock react to earnings?
ACRV stock has moved an average of -0.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.